Member Info for one4one

Onwards and sidewards the next patients treated will lift the share price "sell into strength" before the share price follows the law of gravity with the endorsement that this is not the final Destination🐭

Autologous the therapy currently leading car-t treatment of which is costly limited to accessibility & can-not be scaled up due to being a 121 custom treatment using the patients own cells with a timely manufacturing process with this in mind the recent adoption of the "made technology with the assistance of Ai/robotic will erase these issues, "scalability remains a issue of concern" though allogenic therapy that is accessible/cost effective due to being scalable is making ground with the recent adaption of splicing cd19flt/cd70 is showing strong signs of by-passing CRS further more with allogenic being scalable reaching a wider audience due to being accessible & having the potential for pre-loaded syringe giving a global audience🐭

Trump threatens china intervention if they supply iran with arms, if China was to call in the Usa debt bonds that would cripple the usa dollar now wouldn`t that be a embarrassment the usa is skint & cannot go to war:-))

Well vlad did not post on linkedin about myeloma the last post from vlad on linkedn was similar to the rns that investors received by investors 🐭

Myeloma is a different field condom i highly recommend brain cell therapy "baseball bat @ hand 🐭

Oh no he has not... lol ....the ramping clowns are getting twitchy /the cohorts enrolled on hemo c/t trial have received a half/optimum dose as a safety clause pending data as the c/t evolves further fresh entrants will receive the full dose providing the data from the half/optimum dose comes positive the nippers joining the c/t will follow the same procedure as the adult cohorts "safety is the priority as there is still caution of the crs symtons

Yawn yet another sermon from a twitchy split personality is like a irritating Gnat....Slap....History....DNR🐭

"Yawn another sermon by the ramping pimp......."mind your own business as my business is just fine 🐭

Your thesis is weak "Watch this space Realy ? with a trading pattern of 9/10.50 and a large spread in between is certainly not a signal to chase green candles🐭

The bulls have a engagement with speculation: "onwards & sidewards until efficacy dater is consistent🐭

Whilst the market is waiting for a update the bulls are speculating & the bears are calculating the truth of reality lye`s somewhere in between🐭

7

And you are not my breed of civilisation in the dustbin you go "Hensse not the green recycling bin lol🐭

Your post contains a lot of personal opinion and insults toward me, play ball & not the man.

this a public forum for a debate bulls v bears jog on to share divers and preach to your disciple's & do not Dictate to me.

expressing other capillary's of science is not a crime if vlads treatment is proven then thats fine by me

your Statements “he has the best treatment” are strong but lets wait & see as the trial is in the early stages speculation is not factual until proven.

agree to disagree Delivering on a “shoe string” budget is impressive, but scaling treatments can be challenging.

i stand by what i have posted hemogenyx Autologous car-t HG-CT-1 may be a break through but the limitations of /time/costs/ scalability & accessibility are true the big pharma will take those points of view into consideration before a collaboration/ i have no beef with vlad or members of this forum in fact i wish them well, but i will counter claim if the blood hounds wander of the trail/scent🐭

You are Warped ! who with a sound mind would be praying for the death of the first child ? repent you have just hit a delicate issue !!! i have longed for a treatment that can eradicate this terrible decease & the innovation of science is on the cusp of doing just that ! though the cell therapy is still in the infancy stage & evolving and is a niche tool, The present technology is Autologous with side effects of CRS costs scalability accessibility ect ect: the science is travelling to Autogenic to eradicate the hurdles of Autologous but is in the early stages of R & D though another direction is Natural Killer cells produced in the human body which may become the metric tool, before you you lose your mind due to working over time May i suggest you take a jog to the Memory Bank before you Lose your Mind & finally if you do not like a post then simply scroll on by

@HereForHemo:-))With costs often exceeding €350,000 per patient per dose, disparities in access constitute a bureaucratic challenge and a significant issue of clinical equity. For patients with relapsed or refractory haematologic malignancies, whose survival may be measured in months, delays in access have direct consequences on outcomes. and here comes the link

https://hospitalpharmacyeurope.com/clinical-zones/haematology/car-t-access-across-europe-approval-versus-availability/

before you bark the above relates to Europe the same will align with the Usa🐭

Closure of the Bab el-Mandeb Strait " Gate of Tears could keep tankers originating in the Persian Gulf from transiting the Suez Canal or reaching the SUMED Pipeline, forcing them to divert around the southern tip of Africa, which would increase transit time and shipping costs.

https://en.wikipedia.org/wiki/Bab-el-Mandeb

The Homarus straits being closed What if Iran Operate plan B and close the Gate of Tears ?

Hg-ct-1 is out on parole from the petri-dish & has a long way to travel before proven, the constraints of car-t align 🐭

@HereForHemo.....Hg-Ct-1 Autologous custom therapy "121" is operating in the same framework that has limited car-t so far/ Manufacturing complexity, high costs, and the need for specialized treatment centers & Qualified staff to do the job remain a persistent barrier. Unless Hg-Ct-1 breaks through to allogeneic off the shelf therapy giving scalability/accessibility/lower costs.....Hg-ct-1 may be classed as a upgrade to the present car-t therapy available in this field today Hg-ct-1 therapy is best viewed as a high-potential evolution rather than being a guarantee before becoming a specialized settings.🐭

Re-buttal is fine ! Full dosage has been quoted as speed kills thou caution as the infused cells overload the system & a concern for CRS.

without getting into a war of words we may agree to disagree, vlad is playing safe & a credit to him by putting the safety of the patients first

half dose/optimum dose the safety data will reveal if the treatment advances to the full dose🐭